Literature DB >> 15463897

'Cepacia syndrome' with Burkholderia multivorans, 9 years after initial colonization.

L Blackburn1, K Brownlee, S Conway, M Denton.   

Abstract

A 16-year-old boy with cystic fibrosis developed 'cepacia syndrome' 9 years after the first isolation of Burkholderia multivorans. It is important to recognise that 'cepacia syndrome' is not restricted to those infected with genomovar type III strains and that rapid, irreversible clinical decline can occur many years after the 1st isolation of Burkholderia cepacia complex (Bcc).

Entities:  

Mesh：

Year:  2004        PMID： 15463897     DOI： 10.1016/j.jcf.2004.03.007

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN： 1569-1993            Impact factor:   5.482


  11 in total

1.  Cystic fibrosis, a Burkholderia cenocepacia chest wall abscess and rapid clinical deterioration.

Authors:  N J Simmonds; K M Gyi
Journal:  J R Soc Med       Date:  2008-07       Impact factor: 5.344

Review 2.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

3.  Gene expression profiling of Burkholderia cenocepacia at the time of cepacia syndrome: loss of motility as a marker of poor prognosis?

Authors:  Lucie Kalferstova; Michal Kolar; Libor Fila; Jolana Vavrova; Pavel Drevinek
Journal:  J Clin Microbiol       Date:  2015-02-18       Impact factor: 5.948

4.  Assessment of fluorescent in situ hybridization and PCR-based methods for rapid identification of Burkholderia cepacia complex organisms directly from sputum samples.

Authors:  A R Brown; J R W Govan
Journal:  J Clin Microbiol       Date:  2007-04-25       Impact factor: 5.948

5.  Cepacia Syndrome in a Non-Cystic Fibrosis Patient.

Authors:  Naomi Hauser; Jose Orsini
Journal:  Case Rep Infect Dis       Date:  2015-08-18

6.  Molecular Simulations of Carbohydrates with a Fucose-Binding Burkholderia ambifaria Lectin Suggest Modulation by Surface Residues Outside the Fucose-Binding Pocket.

Authors:  Tamir Dingjan; Anne Imberty; Serge Pérez; Elizabeth Yuriev; Paul A Ramsland
Journal:  Front Pharmacol       Date:  2017-06-21       Impact factor: 5.810

7.  The involvement of the low-oxygen-activated locus of Burkholderia cenocepacia in adaptation during cystic fibrosis infection.

Authors:  Louise Cullen; Andrew O'Connor; Sarah McCormack; Rebecca A Owens; Giles S Holt; Cassandra Collins; Máire Callaghan; Sean Doyle; Darren Smith; Kirsten Schaffer; David A Fitzpatrick; Siobhán McClean
Journal:  Sci Rep       Date:  2018-09-06       Impact factor: 4.379

8.  The afc antifungal activity cluster, which is under tight regulatory control of ShvR, is essential for transition from intracellular persistence of Burkholderia cenocepacia to acute pro-inflammatory infection.

Authors:  Margarida C Gomes; Yara Tasrini; Sujatha Subramoni; Kirsty Agnoli; Joana R Feliciano; Leo Eberl; Pamela Sokol; David O'Callaghan; Annette C Vergunst
Journal:  PLoS Pathog       Date:  2018-12-04       Impact factor: 6.823

9.  Understanding the Pathogenicity of Burkholderia contaminans, an Emerging Pathogen in Cystic Fibrosis.

Authors:  Jaroslav Nunvar; Lucie Kalferstova; Ruhi A M Bloodworth; Michal Kolar; Jose Degrossi; Silvina Lubovich; Silvia T Cardona; Pavel Drevinek
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

10.  Lipopolysaccharides from Different Burkholderia Species with Different Lipid A Structures Induce Toll-Like Receptor 4 Activation and React with Melioidosis Patient Sera.

Authors:  Sineenart Sengyee; Sung Hwan Yoon; T Eoin West; Robert K Ernst; Narisara Chantratita
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.